Snapshot of the Global Therapeutic Landscape of Acromegaly to Deliver by Research Available at The Market Reports
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acromegaly - Pipeline Review, H1 2018, provides an overview of the Acromegaly (Hormonal Disorders) pipeline landscape.
(EMAILWIRE.COM, April 04, 2018 ) Acromegaly is a hormonal disorder that develops when pituitary gland produces too much growth hormone during adulthood. Symptoms include body odor, easy fatigue, headache, large feet, excessive height, swelling of the bony areas around a joint, widely spaced teeth and sleep apnea. Treatment includes surgery, dopamine agonists and growth hormone antagonists.
Report Source: https://www.themarketreports.com/report/acromegaly-pipeline-review-h1-2018
Reasons to buy
Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Find and recognize significant and varied types of therapeutics under development for Acromegaly (Hormonal Disorders).
Classify potential new clients or partners in the target demographic.
Develop tactical initiatives by understanding the focus areas of leading companies.
Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
Formulate corrective measures for pipeline projects by understanding Acromegaly (Hormonal Disorders) pipeline depth and focus of Indication therapeutics.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Purchase this report at: https://www.themarketreports.com/report/buy-now/1036780
Companies Mentioned
Aegis Therapeutics LLC
Amryt Pharma plc
Antisense Therapeutics Ltd
Aquestive Therapeutics
Chiasma Inc
Crinetics Pharmaceuticals Inc
Daewoong Pharmaceutical Co Ltd
Dauntless Pharmaceuticals Inc
DexTech Medical AB
Ionis Pharmaceuticals Inc
Italfarmaco SpA
leon-nanodrugs GmbH
Midatech Pharma Plc
Novartis AG
Peptron Inc
Silence Therapeutics Plc
Strongbridge Biopharma plc
Sun Pharmaceutical Industries Ltd
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1036780
Report Source: https://www.themarketreports.com/report/acromegaly-pipeline-review-h1-2018
Reasons to buy
Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Find and recognize significant and varied types of therapeutics under development for Acromegaly (Hormonal Disorders).
Classify potential new clients or partners in the target demographic.
Develop tactical initiatives by understanding the focus areas of leading companies.
Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
Formulate corrective measures for pipeline projects by understanding Acromegaly (Hormonal Disorders) pipeline depth and focus of Indication therapeutics.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Purchase this report at: https://www.themarketreports.com/report/buy-now/1036780
Companies Mentioned
Aegis Therapeutics LLC
Amryt Pharma plc
Antisense Therapeutics Ltd
Aquestive Therapeutics
Chiasma Inc
Crinetics Pharmaceuticals Inc
Daewoong Pharmaceutical Co Ltd
Dauntless Pharmaceuticals Inc
DexTech Medical AB
Ionis Pharmaceuticals Inc
Italfarmaco SpA
leon-nanodrugs GmbH
Midatech Pharma Plc
Novartis AG
Peptron Inc
Silence Therapeutics Plc
Strongbridge Biopharma plc
Sun Pharmaceutical Industries Ltd
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1036780
Contact Information:
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results